))
Consumer’s health, COVID-19 and clinical research
Manage episode 285854550 series 2091186
Content provided by Informa Markets. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Informa Markets or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Understanding the impact of COVID-19 on clinical research in the consumer healthcare space.
COVID-19 has accelerated many changes in clinical research, particularly in the consumer healthcare space. While natural health products are increasingly attractive to consumers, the pandemic has caused significant disruptions to the clinical trial enterprise. Felix Alt, Head of Clinical Operations at Analyze and Realize, discusses both the challenges and the opportunities COVID-19 has brought to clinical research and consumer healthcare. Tune in to learn about:
- Why natural health products are increasingly attractive in COVID-19 times
- How this trend is shaping consumer’s health clinical research
- How Clinical Research Organisations (CROs) are adapting to the pandemic, including patient recruitment and the accelerated role of digitalisation
200 episodes
Share
